ADMA Biologics
ADMA
ADMA
34 hedge funds and large institutions have $78M invested in ADMA Biologics in 2018 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 2 closing their positions.
Holders
34
Holders Change
+11
Holders Change %
+47.83%
% of All Funds
0.78%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
13
Increased
9
Reduced
6
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$4.08M |
2 |
2
Millennium Management
New York
|
$1.26M |
3 |
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$435K |
4 |
4
Goldman Sachs
New York
|
$429K |
5 |
![]()
5
JPMorgan Chase & Co
New York
|
$182K |